7
May 28, 20267 Retatrutide Surprises Surpass Semaglutide's Pitfalls in Rare Obesity
New data shows retatrutide may cut hypertension and liver enzyme spikes better than tirzepatide for rare MC4R‑deficient obesity. Discover the seven ways it beat
May 28, 20261 min read0 reactions0 comments